U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$83.86 USD
+0.81 (0.98%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $84.02 +0.16 (0.19%) 5:34 PM ET
4-Sell of 5 4
C Value B Growth F Momentum C VGM
U.S. Physical Therapy (USPH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$115.38 | $122.50 | $108.00 | 38.93% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for U.S. Physical Therapy comes to $115.38. The forecasts range from a low of $108.00 to a high of $122.50. The average price target represents an increase of 38.93% from the last closing price of $83.05.
Analyst Price Targets (4 )
Broker Rating
U.S. Physical Therapy currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
8/13/2024 | William Blair | Jared Haase | Hold | Hold |
7/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 5 |
Average Target Price | $115.38 |
LT Growth Rate | 8.10% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 46 of 253 |
Current Quarter EPS Est: | 0.69 |
USPH FAQs
U.S. Physical Therapy, Inc. (USPH) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for U.S. Physical Therapy, Inc. (USPH) is $115.38. The current on short-term price targets is based on 5 reports.
The forecasts for U.S. Physical Therapy, Inc. (USPH) range from a low of $108 to a high of $122.5. The average price target represents a increase of $38.93 from the last closing price of $83.05.
The current UPSIDE for U.S. Physical Therapy, Inc. (USPH) is 38.93%
Based on short-term price targets offered by four analysts, the average price target for U.S. Physical Therapy comes to $115.38. The forecasts range from a low of $108.00 to a high of $122.50. The average price target represents an increase of 38.93% from the last closing price of $83.05.